REGN1908-1909
R1908-HV-1240
Phase 1 small_molecule completed
Quick answer
REGN1908-1909 for Allergy is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Allergy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed